Please login to the form below

Not currently logged in
Email:
Password:

Abexinostat

This page shows the latest Abexinostat news and features for those working in and with pharma, biotech and healthcare.

Servier announces job cuts as pressures mount

Servier announces job cuts as pressures mount

Servier has also had some pipeline setbacks of late. Last year the company abandoned development of its HDAC inhibitor abexinostat for cancer, returning rights to Pharmacyclics, while in October it walked

Latest news

More from news
Approximately 1 fully matching, plus 2 partially matching documents found.

Latest Intelligence

  • Deal Watch March 2017 Deal Watch March 2017

    And finally, Xynomic, the US/China biopharmaceutical company has picked up two products: ACAT-1 from the US company Resarci Therapeutics and abexinostat from a mystery seller who Xynomic declined to ... name. (Abexinostat was formerly in development by

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
emotive.

emotive. is an award-winning healthcare communications agency working with leading global and EMEA companies in life sciences including medical device...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics